Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 4Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Precancerous Conditions 2Lung Neoplasms 2Vascular Diseases 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Radiation-induced Injuries in Patients With Rectal Cancer 1Radiation Injuries 1Neurotoxicity Syndromes 1Neoplasms 1Myocardial Ischemia 1Myocardial Infarction 1Heart Diseases 1Head and Neck Neoplasms 1Depression 1Delirium 1Coronary Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cerebrovascular Disorders 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Adenomatous Polyps 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Prednisone 9Pemetrexed 9Epoetin Alfa 9venetoclax 8atezolizumab 8Fentanyl 8Drug Therapy 8Doxorubicin 8Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Vitamin E × Clear all
NCT00272428 2009-12-17

Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
13,000 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡